Carcinogenesis Advance Access originally published online on June 5, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 24, No. 8, 1325-1336,
August 2003
© 2003 Oxford University Press
CANCER BIOLOGY |
Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPAR
in cell invasion process
1 INSERM U427, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes, Paris 5, F-75006 Paris, France
2 INRA, UMR 955 de Génétique Moléculaire et Cellulaire, Ecole Vétérinaire d'Alfort, F-94704 Maisons-Alfort, France
3 Laboratoire de Biologie Moléculaire de la Différenciation, Université Paris 7, F-75005 Paris, France
4 Laboratoire de Génétique Moléculaire—UPRES JE 2195, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes, Paris 5, F-75006 Paris, France
5 Laboratoire de Biochimie, Faculté des Sciences Pharmaceutiques et Biologiques, Université René Descartes, Paris 5, F-75006 Paris, France
6 To whom correspondence should be addressed Email: t.fournier{at}pharmacie.univ-paris5.fr
Invasive cytotrophoblasts play a key role in the development of human placenta and is therefore essential for subsequent development of the embryo. Human implantation is characterized by a major trophoblastic invasion that offers a unique model of a controlled and oriented tumor-like process. The ligand-activated nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR
) modulates cell growth and differentiation and might be therefore considered as a tumor suppressor. We have recently reported that PPAR, in synergy with its dimerization partner retinoid X receptor (RXR)
, controls the invasion of human primary cytotrophoblasts. Because these cells are unable to replicate in culture, we have, in the present study, transformed these primary cells with the simian virus 40 large T antigen for studying the role of PPAR in cell invasion process. Our results show that the cell line human invasive proliferative extravillous cytotrophoblast (HIPEC) 65 expressed markers of human invasive primary cytotrophoblast as determined by immunocytochemistry, immunobloting and real-time RT–PCR, and were highly invasive in vitro. We have next studied the role of PPAR/RXR heterodimers in cell proliferation and invasion. Our results show that PPAR and RXR are co-expressed by HIPEC 65 and that, as commonly observed, activation of PPAR/RXR heterodimers with the specific PPAR agonist rosiglitazone induced lipid droplet accumulation as revealed by oil red O staining. Treatment with rosiglitazone or with the natural PPAR agonist 15-deoxy-
-(12,14) PGJ2 did not modify cell growth, but interestingly, activation of PPAR by this synthetic (rosiglitazone) or natural (15d-PGJ2) ligand markedly inhibited cell invasion in a concentration-dependent manner. Finally, we showed that other potential natural PPAR ligand such as oxidized—but not native—low-density lipoprotein inhibited cell invasion. This proliferative and invasive human cytotrophoblast cell line from extravillous origin provides a new tool for studying specifically the role of PPAR in the control of cell invasion.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Novakovic, M. Sibson, H. K. Ng, U. Manuelpillai, V. Rakyan, T. Down, S. Beck, T. Fournier, D. Evain-Brion, E. Dimitriadis, et al. Placenta-specific Methylation of the Vitamin D 24-Hydroxylase Gene: IMPLICATIONS FOR FEEDBACK AUTOREGULATION OF ACTIVE VITAMIN D LEVELS AT THE FETOMATERNAL INTERFACE J. Biol. Chem., May 29, 2009; 284(22): 14838 - 14848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Handschuh, J. Guibourdenche, V. Tsatsaris, M. Guesnon, I. Laurendeau, D. Evain-Brion, and T. Fournier Human Chorionic Gonadotropin Produced by the Invasive Trophoblast But Not the Villous Trophoblast Promotes Cell Invasion and Is Down-Regulated by Peroxisome Proliferator-Activated Receptor-{gamma} Endocrinology, October 1, 2007; 148(10): 5011 - 5019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Harun, L. Ruban, M. Matin, J. Draper, N.M. Jenkins, G.C. Liew, P.W. Andrews, T.C. Li, S.M. Laird, and H.D.M. Moore Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation events Hum. Reprod., June 1, 2006; 21(6): 1349 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cohen, A. Meisser, L. Haenggeli, and P. Bischof Involvement of MAPK pathway in TNF-{alpha}-induced MMP-9 expression in human trophoblastic cells Mol. Hum. Reprod., April 1, 2006; 12(4): 225 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. B. E. Berry, J. A. Keelan, R. J. A. Helliwell, R. S. Gilmour, and M. D. Mitchell Nanomolar and Micromolar Effects of 15-Deoxy-{Delta}12,14-prostaglandin J2 on Amnion-Derived WISH Epithelial Cells: Differential Roles of Peroxisome Proliferator-Activated Receptors {gamma} and {delta} and Nuclear Factor {kappa}B Mol. Pharmacol., July 1, 2005; 68(1): 169 - 178. [Abstract] [Full Text] [PDF]
|
|